Abbott Laboratories (ABT): Price and Financial Metrics
Abbott Laboratories (ABT)
Today's Latest Price: $86.35 USD
0.38 (0.44%)
Updated Dec 13 12:00am
Add ABT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ABT Stock Summary
- ABT has a higher market value than 99.05% of US stocks; more precisely, its current market capitalization is $145,402,428,065.
- ABT's went public 33.97 years ago, making it older than 92.37% of listed US stocks we're tracking.
- The volatility of Abbott Laboratories's share price is greater than that of only 10.02% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Abbott Laboratories are MDT, CRM, TMO, IBM, and UTX.
- Visit ABT's SEC page to see the company's official filings. To visit the company's web site, go to www.abbott.com.
ABT Daily Price Range
ABT 52-Week Price Range
ABT Stock Price Chart More Charts
ABT Price/Volume Stats
| Current price | $86.35 | 52-week high | $88.76 |
| Prev. close | $85.97 | 52-week low | $65.44 |
| Day low | $85.78 | Volume | 3,872,200 |
| Day high | $86.71 | Avg. volume | 5,233,576 |
| 50-day MA | $83.21 | Dividend yield | 1.49% |
| 200-day MA | $81.87 | Market Cap | 152.71B |
Abbott Laboratories (ABT) Company Bio
Abbott Laboratories manufactures and sells health care products worldwide. The company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The company was founded in 1888 and is based in Abbott Park, Illinois.
Top Stories View All
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
Best & Worst Performing Mega Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...